|
Volumn 122, Issue 4, 2009, Pages 329-332
|
Office Management of Chronic Systolic Heart Failure
|
Author keywords
Chronic disease; Drug therapy; Heart failure; Medical management; Systolic
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALDOSTERONE ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUMETANIDE;
CALCIUM CHANNEL BLOCKING AGENT;
CANDESARTAN;
CAPTOPRIL;
CARVEDILOL;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
EPLERENONE;
FUROSEMIDE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDRALAZINE;
HYDROCHLOROTHIAZIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ISOSORBIDE DINITRATE;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
METOLAZONE;
METOPROLOL;
NITRIC ACID DERIVATIVE;
RAMIPRIL;
SPIRONOLACTONE;
TORASEMIDE;
TRANDOLAPRIL;
UNINDEXED DRUG;
VALSARTAN;
ALCOHOL CONSUMPTION;
ARTICLE;
BLOOD PRESSURE;
CHRONIC DISEASE;
CONSULTATION;
CORONARY ARTERY DISEASE;
DIET RESTRICTION;
DISEASE COURSE;
DRUG CONTRAINDICATION;
DRUG INDICATION;
EXERCISE;
HEART ATRIUM FIBRILLATION;
HEART INFARCTION;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEPATITIS;
HUMAN;
HYPERKALEMIA;
HYPERLIPIDEMIA;
KIDNEY FAILURE;
LIFESTYLE MODIFICATION;
LIPID BLOOD LEVEL;
LOW DRUG DOSE;
MYOSITIS;
PRIORITY JOURNAL;
RISK FACTOR;
SMOKING CESSATION;
SURVIVAL;
SYSTOLIC HEART FAILURE;
TREATMENT INDICATION;
|
EID: 63049104844
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjmed.2008.12.011 Document Type: Note |
Times cited : (1)
|
References (7)
|